Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HPIM Gastro > 368: Liver Transplantation > Flashcards

368: Liver Transplantation Flashcards

1
Q

The preferred and technically most advanced approach in liver transplantation : native organ is removed and donor organ is inserted in the same anatomic location

A

Orthotopic transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Replacement of native, diseased liver by a normal organ (allograft)

A

Liver transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who are the potential candidates for liver transplantation?

A

Children and adults who, in the absence of contraindication, suffer from severe irreversible liver disease for which alternative medical or surgical treatments have been exhausted or are unavailable.

See Table 368-1 for list of all indications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most common indication of liver transplantation in children

A

Biliary atresia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T or F:

Liver transplantation is indicated for end-stage cirrhosis of all causes

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common indications for liver transplantation in adults

A

Chronic hepatitis C

Alcoholic liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ABSOLUTE contraindications for transplantation

A
  1. Life threatening systemic diseases
  2. Uncontrolled extrahepatic bacterial or fungal infections
  3. Preexisting advanced cardiovascular or pulmonary disease
  4. Multiple uncorrectable life-threatening congenital anomalies
  5. Metastatic malignancy
  6. Active drug or alcohol abuse

See Table 368-2 for all absolute and relative contraindications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Criteria for organs of brain-dead donors up to age 60 are acceptable

A
  1. Hemodynamic instability
  2. Adequate oxygenation
  3. Absence of bacterial or fungal infection
  4. Absence of abdominal trauma
  5. Absence of hepatic dysfunction
  6. Serologic exclusion of Hepatitis B and C, and HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T or F:

For transplantation to proceed, donor and recipient should be compatible in ABO blood group and organ size.

A

False.

It can be performed in emergencies or marked donor scarcity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A reasonable limit for cold ischemic time, wherein donor liver is removed and packed in ice before transplantation

A

12 hours

Using University of Wisconsin (UW) solution, time can extend up to 20 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5 variables in Child-Turcotte-Pugh (CTP) score

A
  1. Encephalopathy stage
  2. Ascites
  3. Bilirubin
  4. Albumin
  5. Prothrombin time

Replaced by MELD score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the best predictor of pretransplantation mortality in liver transplant?

A

MELD score

MELD scores <15 has higher posttransplantation mortality

Policy: allocate donor organs to candidates with MELD scores >15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Variables of MELD score

A
  1. Bilirubin
  2. Creatinine
  3. Prothombin time expressed as INR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T or F:

Serum potassium is another important predictor of survival in liver transplantation candidates.

A

False

Serum SODIUM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Status 1 or highest priority set by United Network for Organ Sharing (UNOS) Liver Transplantation Waiting List Criteria

A

Fulminant hepatic failure (including primary graft nonfunction and hepatic artery thrombosis within 7 days after transplantation as well as acute decompensated Wilson’s diease)

For children <18, status 1 includes acute or chronic liver failure + hospitalization in an ICU or inborn errors of metabolism;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Validated predictor of survival in patients with liver disease

A

Creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

For children <18, Pediatric End-stage Liver Disease (PELD) scale is used. What are its variables?

A
  1. Albumin
  2. Bilirubin
  3. INR
  4. Growth failure
  5. Age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T or F:

One cadaver organ can be split between 2 recipients (1 adult and 1 child)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Alternative liver donor aside from cadaver donors.

A

Healthy adult donor

Right lobe or left lobe can be donated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risks of healthy liver donor

A
  1. Mean of 10 weeks of medical instability
  2. Biliary complication in 5%
  3. Postop complications: wound infection, small-bowel obstruction, incisional hernias, death)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Risks in liver recipients using healthy liver donors

A

Increased frequency of biliary and vascular complications

22
Q

T or F: Potential donors must participate voluntarily without coercion.

A

True

23
Q

Criteria for living donors

A
  1. 18-60 years old
  2. Compatible blood type with recipient
  3. No chronic medical problems or history of major abdominal surgery
  4. Related genetically or emotionally(??) to the recipient
  5. Pass an exhaustive series of clinical, biochemical and serologic evaluations to unearth disqualifying medical disorders
24
Q

During the anhepatic phase (native liver is removed) what conditions can be encountered on the patient?

A
  1. Coagulopathy
  2. Hypoglycemia
  3. Hypocalcemia
  4. Hypothermia

Must be managed by anedthesiology team

25
Q

Sequence of anastomoses in orthotopic liver transplantation

A
  1. Suprahepatic and infrahepatic vena cava
  2. Portal vein
  3. Hepatic artery
  4. Common bile duct-to-duct anastomosis
26
Q

Duration of transplant operation

A

8hours (6-18hours)

27
Q

Type of transplantation wherein donor liver is inserted without removal of native liver

A

Heterotopic liver transplantation

has very limited success and acceptance

28
Q

Recipients of left and right lobes of the liver

A

Left lobe: Children or small adults

Right lobe : Adults

29
Q

Calcineurin inhibitor used as immunosuppresive agent that blocks early activation of T cells and is specific for T cell functions that result from the interaction of the T cell with its receptor and that involve the calcium-dependent signal transduction pathway

A

Cyclosporine (IV)

30
Q

Most common and important side effect of cyclosporine therapy

A

Nephrotoxicity (Reversible)

Dose-dependent renal tubular injury
Direct renal artery vasospasm

31
Q

Adverse effects of cyclosporine therapy

A 
Hypertension
Hyperkalemia
Tremor
Hirsutism
Glucose intolerance
Gingival hyperplasia
32
Q

A macrolide lactone antibiotic isolated from a Japanese soil fungus, Streptomyces tsukubaensis, that has same mechanism of action as cyclosporine as immunosuppresive agent but is 10-100 times more potent

A

Tacrolimus (oral)

33
Q

Advantages of Tacrolimus

A
  1. Minimizing episodes of rejection
  2. Reducing the need for additional glucocorticoid doses
  3. Reducing the likelihood of bacterial and cytomegalovirus (CMV) infection
  4. Oral absorption more predictable
  5. Does not cause hirsutism and gingival hyperplasia
34
Q

Side effects of Tacrolimus

A
  1. Nephrotoxic

2. Neurotoxic (tremor, seizures, hallucinations, psychoses, coma)

35
Q

This drug inhibits cytochrome P450 however is used occasionally to help boost Tacrolimus levels

A

Itraconazole

36
Q

Cyclosporine and Tacrolimus are both associated with this risk

A

Lymphoproliferative malignancies

Preferred regimens: Combine with Prednisone and an antimetabolite (azathioprine or mycophenolic acid)

37
Q

A nonnucleoside purine metabolism inhibitor derived as a fermentation product from several Penicillium species, used as immunosuppresive drug for post liver transplants

A

Mycophenolic acid

38
Q

Most common adverse effects of Mycophenolate

A

Bone marrow suppression

GI complaints

39
Q

In patients with pretransplantation renal dysfunction or renal deterioration, tacrolimus and cyclosporine may not be practical. What can be used?

A 
Antithymocyte globulin (ATG, thymoglobulin)
Monoclonal antibodies to T cells, OKT3
40
Q

These drugs has been demonstrated to be effective in preventing rejection with improvement in renal function however due to increased hepatic artery thrombosis, these are not recommended as immunosuppresants.

A

Sirolimus

Everolimus

41
Q

T or F: In general, given sufficient immunosuppresion, acute liver allograft rejection is nearly always reversible.

A

True

42
Q

T or F: Prophylactic antibiotic therapy are administered routinely in immediate postoperative period

A

True

43
Q

Antiviral prophylaxis for CMV post liver transplant

A

Ganciclovir

44
Q

Antibiotic prophylaxis for Pneumocystis carinii pneumonia post liver transplant

A

Co-trimoxazole

45
Q

Other leading cause of late mortality after liver transplantation

A

Renal failure

Cardiovascular disease

46
Q

Hepatic complications post liver transplant

A
  1. Primary graft failure
  2. Vascular compromise secondary to thrombosis or stenosis of portal vein
  3. Failure or stricture of the biliary anastomoses
  4. Rejection
47
Q

When does transplant rejection begins?

A

1-2 weeks after surgery

48
Q

Clinical signs suggesting rejection

A

Fever
RUQ pain
Reduced bile pigment and volume
Leukocytosis

Most reliable indicators:
Increase in serum bilirubin and aminotransferase levels

49
Q

Treatment of transplant rejection

A

IV Methylprenisolone in repeated boluses
Thymoglobulin
OKT3

50
Q

Chronic rejection

A

Relatively rare
Progressive cholestasis
Focal parenchymal necrosis, mononuclear infiltration, vascular lesions

HPIM Gastro (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions